dalteparin has been researched along with Acidosis, Renal Tubular Type IV in 1 studies
Dalteparin: A low-molecular-weight fragment of heparin, prepared by nitrous acid depolymerization of porcine mucosal heparin. The mean molecular weight is 4000-6000 daltons. It is used therapeutically as an antithrombotic agent. (From Merck Index, 11th ed)
Excerpt | Relevance | Reference |
---|---|---|
"The cause of hyperkalemia is frequently iatrogenic." | 1.72 | [Hyperkalemia due to low-molecular-weight heparin]. ( Appelman-Dijkstra, NM; den Exter, PL; Koopman, JJEB; van der Heiden, W, 2022) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
van der Heiden, W | 1 |
Koopman, JJEB | 1 |
Appelman-Dijkstra, NM | 1 |
den Exter, PL | 1 |
1 other study available for dalteparin and Acidosis, Renal Tubular Type IV
Article | Year |
---|---|
[Hyperkalemia due to low-molecular-weight heparin].
Topics: Anticoagulants; Heparin; Heparin, Low-Molecular-Weight; Humans; Hyperkalemia; Hypoaldosteronism; Mal | 2022 |